Navigation Links
Collegium Pharmaceutical to Present at Piper Jaffray's 24th Annual Healthcare Conference
Date:11/27/2012

CUMBERLAND, R.I., Nov. 27, 2012 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, is pleased to announce it will present at Piper Jaffray's 24th Annual Healthcare Conference, taking place at the Palace Hotel in New York City from November 27 – 28, 2012.

Collegium President and CEO, Michael Heffernan, is scheduled to present at 1:30PM on Wednesday, November 28th.

About DETERx® Technology

The DETERx® drug delivery platform consists of a multi-particulate matrix formulation in a capsule.  While developed primarily to provide tamper-resistant properties to protect against common methods of tampering such as chewing, crushing, snorting and extraction for IV injection, the multi-particulate design is expected to enable patients with difficulty swallowing to open the capsule and administer the contents on food or via a gastronomy tube, while maintaining the extended release properties of the product. DETERx® technology can be used with drugs that are commonly abused such as opioids and amphetamines, as well as drugs that have narrow therapeutic windows that would benefit from protection against misuse such as breaking, crushing, grinding or dissolving the product. The formulation platform is covered by U.S. and international patents and patent applications. COL-003 is the first of a number of product candidates using the DETERx® platform.

About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx® formulation platform for the treatment of chronic pain. The DETERx® oral drug delivery technology provides extended-release delivery, unique tamper-resistant properties, a
'/>"/>

SOURCE Collegium Pharmaceutical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... DIEGO , Sept. 14, 2014 HUYA ... global development of China,s pharmaceutical ... Institute of Pharmaceutical Research (TIPR) to develop medical ... and the western world, for global markets. ... venture, to be known as TIPR-HUYA Advancing Innovative Medicines ...
(Date:9/14/2014)... , Sept. 14, 2014  Amgen (NASDAQ: AMGN ... S ystolic H eart failure treatment with the ... ivabradine T rial) study evaluating ivabradine in patients with ... Annual Scientific Meeting of the Heart Failure Society of ... post-hoc analysis from the SHIFT study confirmed low systolic blood ...
(Date:9/14/2014)... DALLAS , Sept. 14, 2014 /PRNewswire-iReach/ -- "Hematoma ... the Hematoma clinical trial scenario. This report provides elemental ... Hematoma. It includes an overview of the trial numbers ... trial conduction across the globe. The databook offers a ... trial status, prominence of the sponsors and also provides ...
Breaking Medicine Technology:HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 2HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 3HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 4Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 2Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 3Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 4Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 5Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 6Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 7Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 8Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 9Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 2Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 3Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 4Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 5
... New study questions ability of human-animal hybrids to generate ... Cell Technology, Inc. (OTC Pink Sheets: ACTC) and its ... the capacity to extensively reprogram adult human cells. The ... journal Cloning and Stem Cells (Editor-in-Chief: Sir ...
... Inc., the leader in the,development of devices for ... start of enrollment in the REALISM (Real World ... continued access,registry. The MitraClip(R) system is currently being ... option for patients suffering from the,effects of mitral ...
Cached Medicine Technology:Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 2Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 3Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 4Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 5First U.S. Patients Enrolled in the REALISM Continued Access Study 2First U.S. Patients Enrolled in the REALISM Continued Access Study 3
(Date:9/14/2014)... 2014 Skin becomes dryer with age. Some ... and not moisturizing properly. However, there are inevitable internal factors ... for. , Two main reasons this occurs: , 1) Loss ... in the skin , During the aging process, skin produces ... responsible for important moisture retention and radiance of skin. ...
(Date:9/14/2014)... (PRWEB) September 15, 2014 This event ... event of “10 Day Fest” Festival Vernissage: Social Gastronomy ... J.C. DISI. Festival Vernissage: Social Gastronomy will bring together ... 30 senior management of international corporations and 30 disadvantaged ... unwanted fresh food. It also aimed to raise the ...
(Date:9/14/2014)... Adults who are planning protection for ... website to find quotes for life insurance online. The ... http://quotespros.com/life-insurance.html is now delivering the price information ... are preparing the rates information for adults through the ... states. As a way to simplify the search process, ...
(Date:9/14/2014)... 2014 When active, the protein called ... human cancers including pancreatic, prostate, lung, colon and bladder. ... A study published today in the journal Nature uses ... Ral proteins: "When you want to keep an alligator ... We took another approach – we put a stick ...
(Date:9/14/2014)... Government support for safe patient handling has ... market , The global patient handling equipment market ... five years. The growth of this market is ... increasing lifestyle diseases such as diabetes and Cardiovascular ... market is driven by factors such as government ...
Breaking Medicine News(10 mins):Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 3Health News:PolyU Invites Professional Chefs and Grassroot Families to Prepare a Feast Using Unwanted Fresh Food Collected from Local Wet Markets 2Health News:Quotes for Life Insurance Now Offered at New Consumer Portal Online 2Health News:Nature: New drug blocks gene driving cancer growth 2Health News:Nature: New drug blocks gene driving cancer growth 3Health News:10.7% CAGR For Patient Handling Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:10.7% CAGR For Patient Handling Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:10.7% CAGR For Patient Handling Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4
... Podiatry ... , ... January 17, 2010 -- Aprima Medical Software , a leading developer of electronic ... Advanced Foot and Ankle Specialists of Brandon, Florida, a two-provider podiatry practice, ...
... Jan. 17 The Leona M. and Harry B. Helmsley Charitable ... $1 million to Doctors Without Borders, $1 million ... to support the work of these organizations in providing medical care, food, ... "After seeing the devastation in Haiti and the suffering of ...
... humans and animals, periodically recurring movements like walking or ... pattern generators" (CPG). Scientists have been using this principle ... one separate CPG was needed for every gait. The ... about whether there is an obstacle in front ...
... by researchers at the University of California, San Diego School ... of inherited blindness affecting children and a gene known as ... lead to new therapies and improved diagnostics for retinal disease, ... Nature Genetics on January 17. A newly ...
... runs out for those who don,t understand risk , SATURDAY, ... you,ll get better and win, right? , Wrong, says a ... beginners -- win less money the more hands they play. ... million online poker hands, suggest that small stakes translate to ...
... ... year old technology. Although this simple test is often used as a baseline ... to moderate cholesterol levels. An affordable, direct access walk-in lab in North Dallas ... The PLAC Test helps identify hidden" cardiovascular risk for stroke and heart attack. ...
Cached Medicine News:Health News:Advanced Foot and Ankle Specialists Improves Efficiency, Workflow With Aprima Electronic Health Record 2Health News:Advanced Foot and Ankle Specialists Improves Efficiency, Workflow With Aprima Electronic Health Record 3Health News:Advanced Foot and Ankle Specialists Improves Efficiency, Workflow With Aprima Electronic Health Record 4Health News:Organized chaos gets robots going 2Health News:Researchers find new insights into inherited retinal disease 2Health News:Novice Poker Players Don't Know When to Walk Away 2Health News:The PLAC Test is Now Available at ANY LAB TEST NOW North Dallas 2
The Optical Tracking System provides a complete solution for image-guided surgery. Precision tracking technology converges with powerful visualization software for optimal surgical planning and navig...
Penfield Dissector #3...
Penfield Dissector #2...
Leroy-Raney scalp clips, sterile, disposable, plastic, ten clips/package....
Medicine Products: